Sign in

Elad Sharon, MD, MPH

@eladsharonmd.bsky.social
347 followers 136 following 25 posts

#MedicalOncologist @DanaFarber posting on #immunotherapy, #drugdevelopment, #irAEs & #HealthEcon. Formerly @theNCI & #CancerMoonshot Adult ImmunoTx Co-Chair

PostsRepliesMedia
Reposted by Elad Sharon, MD, MPH
Benjamin P. Geisler @ben-geisler.com · 19/06/2026
New paper in PharmacoEconomics: our systematic review of structured expert elicitation (SEE) in health economic evaluations, 2017–2026. 28 studies. Methods vary widely — standardization & validation urgently needed.
link.springer.com
Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update
PharmacoEconomics - Structured expert elicitation (SEE) has become increasingly important in health technology assessment and economic evaluations. Complementing previous work, we aimed to...
011
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 09/05/2026
Can’t Wait to Share The Abstract on SCLC During SNO/ASCO CNS Metastases Conference - Laura Alder @lauraaldermd.bsky.social oncodaily.com/voices/laura... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
oncodaily.com
Laura Alder: Can't Wait to Share The Abstract on SCLC During SNO/ASCO CNS Metastases Conference - OncoDaily
Laura Alder: Can't Wait to Share The Abstract on SCLC During SNO/ASCO CNS Metastases Conference / boston, cancer, Laura Alder, OncoDaily, Oncology, Westin
031
Reposted by Elad Sharon, MD, MPH
Dana-Farber Cancer Institute @danafarber.bsky.social · 09/05/2026
Since launching her lab in 1998, Kornelia Polyak, MD, PhD, has focused on a fundamental question: how does breast cancer form? New research suggests that shifts in immune activity may be one of the earliest steps. Learn more: bit.ly/4sXDUP3
Kornelia Polyak, MD, PhD, in her lab.
081
Reposted by Elad Sharon, MD, MPH
Fred Hutch @fredhutch.org · 19/04/2026
Fred Hutch #AACR26: Watch Dr. Chris Li present at the Advances in Prevention Research session on "Precision Screening: Opportunities to Enhance the Benefits of Cancer Screening" Sunday, April 19th at 1 p.m. PDT bit.ly/4epxwfU
Fred Hutch at AACR 26, Christopher Li, 
MD, PhD
Presenting: Precision Screening: Opportunities to Enhance the Benefits of Cancer Screening
Sunday, April 19 
1 p.m. PT
Room 5 - Upper Level
011
Reposted by Elad Sharon, MD, MPH
Fred Hutch @fredhutch.org · 19/04/2026
Fred Hutch #AACR26: Watch Dr @TrangVoPham present at the Advances in Population Sciences session on "Advances in the Use of Geospatial and Neighborhood Data for Cancer Population Sciences Research and Translation" Sunday, April 19th at 1 p.m. PDT bit.ly/483jM6E
Fred Hutch at AACR 26, Trang VoPham,  PhD MPH, MS. Photo of Trang VoPham
Presenting: Advances in the Use of Geospatial and Neighborhood Data for Cancer Population Sciences Research and Translation
Sunday, April 19 
1 p.m. PT
Room 17 - Mezzanine Level
021
Reposted by Elad Sharon, MD, MPH
Fred Hutch @fredhutch.org · 19/04/2026
Fred Hutch #AACR26: Watch Kevin Cheung, MD present at the major symposium session on "The Necrotic Tumor Microenvironment as an Instigator of Metastatic Aggression and Immuno‑evasion" Sunday, April 19th at 1 p.m. PDT bit.ly/3QsxBFH
Fred Hutch at AACR 26, Kevin Cheung, MD
Presenting: The Necrotic Tumor Microenvironment as an Instigator of Metastatic Aggression and Immuno‑evasion
Sunday, April 19 
1 p.m. PT
Room 14 - Mezzanine Level
031
Reposted by Elad Sharon, MD, MPH
Nature Portfolio @natureportfolio.nature.com · 13/04/2026
Myriam Chalabi is the Grand Prize Winner of the 2026 Innovators in Science Award. She was recognized for transformative research redefining the standard of care for patients with mismatch repair–deficient (dMMR) colon cancer. Learn more  go.nature.com/4c99DaO   #medsky #WomeninSTEM
Myriam Chalabi receives the Grand Prize for the 2026 Innovators in Science Award. She stands at a podium with the winner medal around her neck and is holding a bouquet of flowers.
1186
Reposted by Elad Sharon, MD, MPH
Miguel Perales MD @drmiguelperales.bsky.social · 14/04/2026
Daily commute to work @mskcancercenter.bsky.social via @citibikenyc.bsky.social
062
Reposted by Elad Sharon, MD, MPH
Nature Portfolio @natureportfolio.nature.com · 09/04/2026
Mummified fossil reptile remails, dated to approximately 289–286 million years ago, show that early amniotes (a group that includes reptiles, birds, and mammals) breathed by moving their ribcages, according to a paper in Nature. go.nature.com/4ctrOIx #Paleosky 🧪
This is figure 3, which shows histological thin sections through the mummified articulated Captorhinus specimen (ROMVP 88565, TS01782 and TS01993).
0155
Reposted by Elad Sharon, MD, MPH
SWOG Cancer Research Network @swog.org · 24/03/2026
Blog post from SWOG chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: SWOG Establishes An APP & Nurse Scientist Cmte Our new cmte recognizes the contributions of APPs to our success & will help empower more of them to contribute to their full scope of practice. www.swog.org/news-events/...
011
Reposted by Elad Sharon, MD, MPH
SWOG Cancer Research Network @swog.org · 19/03/2026
Front Line post from @swog.org group chairs @drdawnhershman.bsky.social & Primo N. Lara, MD: The Next Era of SWOG Success In our vision, we focus even more intensively on studies that tackle the vital questions only public-powered research will answer. www.swog.org/news-events/...
012
Reposted by Elad Sharon, MD, MPH
NPR @npr.org · 10/03/2026
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder. n.pr/4riWRef
n.pr
GLP-1s have transformed weight loss and diabetes. Is addiction next?
A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.
620839
Reposted by Elad Sharon, MD, MPH
SWOG Cancer Research Network @swog.org · 04/03/2026
Saying Thank You: Dr. Charles Blanke's last Front Line post as chair of @swog.org: "I have been honored to serve as chair of this research group over the last 13 years, and I could not be prouder of what you have accomplished in that time." www.swog.org/news-events/...
021
Reposted by Elad Sharon, MD, MPH
Nature Portfolio @natureportfolio.nature.com · 28/02/2026
The preference of some mosquitoes in the Leucosphyrus Group of Anopheles mosquitoes for feeding on humans may have evolved in response to the arrival of early hominins in Southeast Asia ~1.8 million years ago. The findings are published in Scientific Reports. 🧪 #evobio
go.nature.com
Early hominin arrival in Southeast Asia triggered the evolution of major human malaria vectors - Scientific Reports
Some species of the Leucosphyrus Group of Anopheles mosquitoes in Southeast Asia are highly anthropophilic and efficient vectors of human malaria parasites, while others primarily feed on non-human primates (NHP) and transmit NHP malaria parasites. The evolutionary history of this group, particularly the origin of anthropophily, was studied using phylogenomic analysis of 2,657 high-confidence nuclear single-copy orthologous genes and 13 mitochondrial protein coding genes from 40 individuals of 11 species. Molecular dating and ancestral state reconstruction revealed that monkey-feeding is ancestral with speciation of monkey-feeding species dating to the Pliocene within Sundaland (Malay peninsula, Borneo, Sumatra and Java) which was covered in tropical rain forests during this period. Although less parsimonious alternatives cannot be excluded, molecular dating, ancestral state reconstruction and reticulation analysis indicated that anthropophily most likely evolved once, involving adaptive introgression, in the early Pleistocene in Sundaland, giving rise to multiple descendent anthropophilic species. Such early origination of anthropophily must necessarily have been in response to the arrival of early hominins (Homo erectus) rather than anatomically modern humans, likely associated with loss and fragmentation of rainforests during the early Pleistocene. The early origination of anthropophily also provides independent non-archaeological evidence supporting the limited fossil record of early hominin colonization in Southeast Asia around 1.8 Mya.
03414
Reposted by Elad Sharon, MD, MPH
Nature Portfolio @natureportfolio.nature.com · 10/02/2026
The findings of a study in Nature Immunology shed vital insight into the role of CD8+ T cells in multiple sclerosis and support an important role of Epstein–Barr virus in MS immunopathology. #Immunosky #medsky 🧪
go.nature.com
Antigen specificity of clonally enriched CD8+ T cells in multiple sclerosis - Nature Immunology
Sabatino and colleagues examine expanded CD8+ T cell clonotypes from a small cohort of multiple sclerosis patients. They identified several cognate peptide epitopes that derive from Epstein–Barr virus, suggesting EBV reactivation may drive pathogenesis in these patients.
0298
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 21/01/2026
For the Time Being, We Can Breathe a Sigh of Relief on NIH and⁦ NCI⁩ Funding - Elad Sharon @eladsharonmd.bsky.social oncodaily.com/voices/elad-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NIH #NCI
oncodaily.com
Elad Sharon: For the Time Being, We Can Breathe a Sigh of Relief on NIH and⁦ NCI⁩ Funding - OncoDaily
Elad Sharon: For the Time Being, We Can Breathe a Sigh of Relief on NIH and⁦ NCI⁩ Funding / cancer, Elad Sharon, NCI, NIH, Norman Sharpless, OncoDaily, Oncology
021
Reposted by Elad Sharon, MD, MPH
Nature Portfolio @natureportfolio.nature.com · 22/01/2026
Giant ancestors of modern-day kangaroos — which previous research has estimated could weigh up to 250 kilograms — may have been able to hop in short bursts, according to research in Scientific Reports. go.nature.com/49OWsJX #evosky 🧪
The heelbone of Procoptodon goliah, the largest-known kangaroo species.  

Credit: Pat Holroyd, UCMP
1225
Reposted by Elad Sharon, MD, MPH
Ajay Major, MD, MBA @majorajay.bsky.social · 07/12/2025
Hematology twins! @mazietsangmd.bsky.social #ASH25 #fASHion cc @ash.hematology.org
0111
Reposted by Elad Sharon, MD, MPH
Dana-Farber Cancer Institute @danafarber.bsky.social · 06/12/2025
Sabine Allam, MD, reports on results from the PROMISE Study, which screened ~30,000 individuals for monoclonal gammopathies. #ASH25
041
Elad Sharon, MD, MPH @eladsharonmd.bsky.social · 04/11/2025
Watching the opening session for the #FriendsOfCancerResearch Annual Meeting! First up: seamless trial designs for rare cancer drug development! You can watch live and online: secure-web.cisco.com/1-aSs6clrewX...
040
Elad Sharon, MD, MPH @eladsharonmd.bsky.social · 04/11/2025
Excited to be speaking on November 4th Friends of Cancer Research annual meeting (#FriendsAM25)! I will be speaking on #ContributionOfEffect (#COE) You can still register online: secure-web.cisco.com/1-aSs6clrewX...
030
Reposted by Elad Sharon, MD, MPH
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 30/10/2025
Our 2025 ACI series concluded with sessions at ACR Convergence (Oct. 23) and APSHO's JADPRO (Oct. 27). Thank you everyone who made this series a roaring success! Missed a program? Access enduring materials: www.sitcancer.org/edu/aci Jeffrey Sparks MD MMSc, Elad Sharon, MD, MPH
031
Reposted by Elad Sharon, MD, MPH
Madhu Pai, MD, PhD @madhupai.bsky.social · 27/10/2025
Measles is back Whooping cough is back Now, diphtheria is staging a return with large outbreaks now in Somalia, Sudan, Yemen and Chad — countries with civil wars or large populations of refugees where vaccination coverage is low... www.nytimes.com/2025/10/27/h... @stephanienolen.bsky.social
nytimes.com
Diphtheria, a Once Vanquished Killer of Children, Is Resurgent
315299
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 20/10/2025
ESMO Presidential Dinner is Kicking Off in Berlin - Vivek Subbiah @viveksubbiah.bsky.social @myesmo.bsky.social oncodaily.com/voices/vivek... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
oncodaily.com
Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin - OncoDaily
Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO Presidential Dinner, ESMO2025, ESMO25,
062
Reposted by Elad Sharon, MD, MPH
Dana-Farber Cancer Institute @danafarber.bsky.social · 19/10/2025
@ptarantinomd.bsky.social explores safety optimization of the next frontier of antibody-drug conjugate development. #ESMO25
081
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 18/10/2025
Lung Cancer Advances at ESMO25 with Stephen V Liu @stephenvliu.bsky.social @myesmo.bsky.social oncodaily.com/not-to-miss/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025
oncodaily.com
Lung Cancer Advances at ESMO25 with Stephen V Liu - OncoDaily
Lung Cancer Advances at ESMO25 with Stephen V Liu / cancer, Corinne Faivre-Finn, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25, Headlines, Martin Reck,
081
Reposted by Elad Sharon, MD, MPH
Wafik S. El-Deiry, MD, PhD, FACP @weldeiry.bsky.social · 06/10/2025
Dr. @pashtoonkasi discussed precision therapy in GI cancer, young CRC is mostly rectal and left-sided, high Her2 in gall bladder cancer, RAS testing on tissue often isn’t back in 2 weeks, liquid biopsy picks up heterogeneity, fusions, resistance mechs, at 2025 @WIN_Consortium Symposium.
131
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 05/10/2025
NRG-LU005 Trial at the ASTRO 67th Annual Meeting: Atezolizumab and BID Radiotherapy in Limited-Stage SCLC oncodaily.com/oncolibrary/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NRG-LU005 #ASTRO25 #SCLC
oncodaily.com
NRG-LU005 Trial QOL Results at ASTRO 67th Annual Meeting
At ASTRO 67, the NRG-LU005 trial reported improved long-term quality of life with atezolizumab and twice-daily radiotherapy in limited-stage SCLC.
062
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 04/10/2025
Elizabeth Mittendorf Named Chief of Multi-Disciplinary Oncology at Dana-Farber and Chief of Breast Surgery at BIDMC @danafarbernews.bsky.social @danafarber.bsky.social @bidmc-cancercenter.bsky.social oncodaily.com/career/eliza... #OncoDaily #Oncology #Cancer #Health #Medicine #MedOnc #MedNews
oncodaily.com
Elizabeth Mittendorf Named Chief of Multi-Disciplinary Oncology at Dana-Farber and Chief of Breast Surgery at BIDMC - OncoDaily
Elizabeth Mittendorf Named Chief of Multi-Disciplinary Oncology at Dana-Farber and Chief of Breast Surgery at BIDMC / BIDMC, cancer, Dana-Farber’s Breast
061
Reposted by Elad Sharon, MD, MPH
John Greally @greally.bsky.social · 04/10/2025
What an amazing assay. DAF-seq, the evolution of Fiber-seq from the Andrew Stergachis group, using the @pacbio.bsky.social platform: www.biorxiv.org/content/10.1... This will revolutionise our understanding of transcriptional regulation and functional non-coding variants.
biorxiv.org
Deaminase-assisted single-molecule and single-cell chromatin fiber sequencing
Gene regulation is mediated by the co-occupancy of numerous proteins along individual chromatin fibers. However, our tools for deeply profiling how proteins co-occupy individual fibers, especially at ...
04113
Reposted by Elad Sharon, MD, MPH
Daniel Drucker @danieljdrucker.bsky.social · 03/10/2025
Inflammation is a key driver of the pathophysiology of cardiometabolic disorders #obesity #T2D and new metabolic medicines based on GLP-1 action exert their magic in part by reducing inflammation. A new review from Professor Donath summarizes the field www.sciencedirect.com/science/arti...?
sciencedirect.com
Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
Obesity and its related disorders, including type 2 diabetes and liver, kidney, and cardiovascular diseases, are now recognized as chronic inflammator…
1154
Reposted by Elad Sharon, MD, MPH
Shirish @shrikrishnans.bsky.social · 30/09/2025
The Paris Summit of Synthetic Biology Centers, organized by @riceuniversity.bsky.social brought together global leaders of SynBio centers, biofoundries, and consortia to work out how to combine forces, grow expertise, fund discovery, and ensure ethical progress. A productive 2 days in Paris!
071
Reposted by Elad Sharon, MD, MPH
Dr Elisa Perego @elisaperego78.bsky.social · 27/09/2025
Olfactory dysfunction is common following SARS-CoV-2 infection, and can be detected on testing even in some who are unaware of having it/ don't report it (occult hyposmia) (US RECOVER study sample) #LongCovid jamanetwork.com/journals/jam...
jamanetwork.com
Olfactory Dysfunction After SARS-CoV-2
This cohort study examines the presence, severity, and patterns of olfactory dysfunction in US adults with and without prior SARS-CoV-2 infection.
15922
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 25/09/2025
Early Pancreatic Cancer Detection Improved with cfDNA Model-CD-AACR - Elizabeth McKenna @elizsmckenna.bsky.social oncodaily.com/voices/377561 #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PancreaticCancer
oncodaily.com
Elizabeth McKenna: Early Pancreatic Cancer Detection Improved with cfDNA Model-CD-AACR - OncoDaily
Elizabeth McKenna: Early Pancreatic Cancer Detection Improved with cfDNA Model-CD-AACR / CD-AACR, Chuntao Gao, Dongqin Zhu, Elizabeth McKenna, Fenglin Zang,
062
Reposted by Elad Sharon, MD, MPH
Stephen Liu @stephenvliu.bsky.social · 26/09/2025
Join us in downtown Washington, DC next Saturday October 4th for the DC Lung Cancer Conference, an IASLC endorsed, 1-day CME meeting covering updates in lung cancer, featuring 58 thoughtful & dynamic faculty members. #DCLung25 Register today at medstarhealth.org/dclung25
061
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 24/09/2025
Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - Vivek Subbiah @viveksubbiah.bsky.social oncodaily.com/voices/vivek... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
oncodaily.com
Vivek Subbiah: Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - OncoDaily
Vivek Subbiah: Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series / cancer, International Cancer Patient Coalition,
052
Reposted by Elad Sharon, MD, MPH
The Hope Foundation for Cancer Research @supportingswog.bsky.social · 24/09/2025
Thanks to all who made our Chicago group meeting a success! It went by too quickly, but it’s always refreshing to see our #SWOGonc community in person. We're grateful for our donors 🙏 And for those who picked up some new @swog.org swag, we’re excited to see where you’ll be spotted wearing it!
032
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 18/09/2025
A Meaningful Week of Science at the WCLC25 - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25
oncodaily.com
Narjust Florez: A Meaningful Week of Science at the WCLC25 - OncoDaily
Narjust Florez: A Meaningful Week of Science at the WCLC25 / cancer, Lung cancer, Narjust Florez, OncoDaily, Oncology, WCLC25
062
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 16/09/2025
Robin Zon Has Been Promoted to Chair of ASCO Society Board @ascocancer.bsky.social oncodaily.com/career/robin... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO
oncodaily.com
Robin Zon Has Been Promoted to Chair of ASCO Society Board - OncoDaily
Robin Zon Has Been Promoted to Chair of ASCO Society Board / American Society of Clinical Oncology, ASCO, cancer, OncoDaily, Oncology, Robin Zon
041
Reposted by Elad Sharon, MD, MPH
The Guardian @theguardian.com · 15/09/2025
‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls
theguardian.com
‘One jab will do the job’: Pakistan begins rollout of HPV vaccine to millions of girls
Despite vaccination hesitancy, the end may be in sight for cervical cancer, which kills 64% of women with the disease
426253
Reposted by Elad Sharon, MD, MPH
Eric Topol @erictopol.bsky.social · 12/09/2025
Partitioning obesity by genomics, proteomics and health outcomes from >450,000 UK Biobank @naturemedicine.bsky.social —A protective subtype vs cardiometabolic diseases (GRS BFP) and —A risk subtype for these diseases (GRS uncoupling) GRS-genomic risk score nature.com/articles/s41...
39118
Reposted by Elad Sharon, MD, MPH
Laudine Carbuccia @laudine.bsky.social · 11/09/2025
1/ Thrilled to share that my main PhD article has just been published in Nature Human Behaviour! 🎉 👉 “A randomised controlled trial on the effect of administrative burden and information costs on social inequalities in early childcare access in France” rdcu.be/eFAEA
rdcu.be
A randomized controlled trial on the effect of administrative burden and information costs on social inequalities in early childcare access in France
Nature Human Behaviour - This RCT finds that providing information and support to target cognitive and behavioural barriers eliminates early childcare application gaps for low-income and immigrant...
712229
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 24/08/2025
Caring Beyond the Diagnosis: UICC’s Global Impact on Cancer Support @uiccofficial.bsky.social oncodaily.com/voices/uicc-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #UICC
oncodaily.com
Caring Beyond the Diagnosis: UICC's Global Impact on Cancer Support - OncoDaily
Caring Beyond the Diagnosis: UICC's Global Impact on Cancer Support / cancer, CANSA The Cancer Association of South Africa, OncoDaily, Oncology, UICC, UICC
071
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 24/08/2025
On the Frontlines: Promoting Awareness of Young Lung Cancer - Narjust Florez @narjustflorezmd.bsky.social oncodaily.com/voices/narju... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #YoungLungCancer
oncodaily.com
Narjust Florez: On the Frontlines - Promoting Awareness of Young Lung Cancer - OncoDaily
Narjust Florez: On the Frontlines - Promoting Awareness of Young Lung Cancer / cancer, cancer awareness, Dana-Farber Cancer Institute, Lung cancer, Narjust
0112
Reposted by Elad Sharon, MD, MPH
Dana-Farber News @danafarbernews.bsky.social · 18/08/2025
Dr. Andy Wagner discusses advances and the ongoing research happening at @danafarber.bsky.social to better diagnose and treat cancer to improve outcomes for patients. Check out the story from Spectrum News 1 Worcester that aired as part of a #StandUp2Cancer special. ➡️ bit.ly/4mP2ZsZ
bit.ly
Dana-Farber in Boston Stands Up to Cancer
Dana-Farber says their mission is simple. It's to envision a world free of the fear and burden of cancer.
042
Elad Sharon, MD, MPH @eladsharonmd.bsky.social · 13/08/2025
Moving to places that encourage more walking leads to more walking… @nature.com
350
Reposted by Elad Sharon, MD, MPH
Vivek Subbiah, MD @viveksubbiah.bsky.social · 11/08/2025
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial - The Lancet www.thelancet.com/journals/lan...
thelancet.com
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
Adagrasib demonstrated a statistically significant improvement in progression-free survival over docetaxel in patients with previously treated KRASG12C-mutated NSCLC, without new safety signals.
152
Reposted by Elad Sharon, MD, MPH
OncoDaily @oncodaily.bsky.social · 09/07/2025
Can Macrophages Revolutionize Cancer Immunotherapy? - Yan Leyfman @yleyfman.bsky.social oncodaily.com/blog/yan-ley... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO #Macrophages #CART
oncodaily.com
Yan Leyfman: Can Macrophages Revolutionize Cancer Immunotherapy? - OncoDaily
Yan Leyfman: Can Macrophages Revolutionize Cancer Immunotherapy? / cancer, OncoDaily, Oncology, Yan Leyfman
192
Reposted by Elad Sharon, MD, MPH
Darcy Burbage, DNP, RN, AOCN @darcyburbage.bsky.social · 27/06/2025
A pleasure to present alongside Drs @michael-jefford.bsky.social #DrLarissaNekhlyudov at today’s #MASCC25 Survivorship Workshop! Thank you to the attendees for your participation! @cancercaremascc.bsky.social
092
Reposted by Elad Sharon, MD, MPH
Dana-Farber News @danafarbernews.bsky.social · 31/05/2025
New data presented at #ASCO25 today by @danafarber.bsky.social's Sara Tolaney, MD, showed an ADC-immunotherapy combination resulted in durable responses with improved PFS among patients with metastatic TNBC when compared to standard treatment. ➡️ bit.ly/3HdmbB2
Sara Tolaney, MD, of Dana-Farber Cancer Institute
062